Adalimumab

All congenital malformations (majors, minors, majors and minors, or unspecified)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S5066
R13191
De Lorenzo (Controls unexposed, disease free), 2020 Malformations at least 1st trimester retrospective cohort unexposed, disease free excluded Adjustment: No 7.67 [0.21;278.90] C
excluded (control group)
0/2   1/36 1 2
ref
S5067
R13197
De Lorenzo (Controls unexposed, sick), 2020 Malformations at least 1st trimester retrospective cohort unexposed, sick Adjustment: No 21.00 [0.30;1469.95] C 0/2   0/32 0 2
ref
S5069
R15979
Chambers (Controls unexposed, disease free), 2019 Major Birth Defects at least 1st trimester prospective cohort unexposed, disease free excluded Adjustment: Yes 1.43 [0.33;6.27]
excluded (control group)
22/221   12/198 34 221
ref
S5068
R15980
Chambers (Controls, sick), 2019 Major Birth Defects at least 1st trimester prospective cohort unexposed, sick Adjustment: Yes 1.10 [0.45;2.73] 22/221   8/106 30 221
ref
S3006
R11357
Hoxha, 2017 Congenital malformation 1st trimester prospective cohort unexposed, sick Adjustment: No 2.50 [0.12;50.45] C 1/5   1/11 2 5
ref
S4061
R11349
Bröms (controls unexposed, disease free), 2016 Any major birth defect 3 months or more before pregnancy or1st trimester population based cohort retrospective unexposed, disease free excluded Adjustment: No 1.35 [0.69;2.64] C
excluded (control group)
9/161   52,592/1,250,192 52,601 161
ref
S3197
R11350
Bröms (controls unexposed, sick), 2016 Any major birth defect 3 months or more before pregnancy or1st trimester excluded population based cohort retrospective unexposed, sick Adjustment: Yes 1.22 [0.58;2.27]
excluded (exposition period)
9/161   1,019/21,549 1,028 161
ref
S2911
R11361
Weber-Schoendorfer, 2015 Major birth defects 1st trimester prospective cohort unexposed, disease free Adjustment: No 4.15 [1.86;9.23] C 9/150   21/1,385 30 150
ref
S3090
R11353
Casanova, 2013 Congenital malformations (NOS) 3 months (or more) before pregnancy or during pregnancy excluded retrospective cohort exposed to other treatment, sick Adjustment: No 21.13 [1.26;354.49] C
excluded (exposition period)
1/16   1/318 2 16
ref
S13724
R53458
Viktil (Controls exposed to other treatments), 2012 Major malformations 3 months or more before pregnancy or1st trimester population based cohort propective exposed to other treatment, sick excluded Adjustment: No 5.57 [0.26;117.63] C
excluded (control group)
0/3   50/1,458 50 3
ref
S13725
R53460
Viktil (Controls unexposed, NOS), 2012 Major malformations 3 months or more before pregnancy or1st trimester excluded population based cohort propective unexposed (general population or NOS) Adjustment: No 6.00 [0.29;124.97] C
excluded (exposition period)
0/3   5,000/154,976 5,000 3
ref
S3121
R4855
Schnitzler (Unexposed control, disease free), 2011 Malformations (NOS) 3 months (or more) before pregnancy or during pregnancy prospective cohort unexposed, disease free excluded Adjustment: No 30.27 [1.10;836.04] C
excluded (control group)
1/7   0/56 1 7
ref
S3122
R4856
Schnitzler (Unexposed control, sick), 2011 Malformations (NOS) 3 months (or more) before pregnancy or during pregnancy excluded prospective cohort unexposed, sick Adjustment: No 12.83 [0.71;231.76] C
excluded (exposition period)
1/7   1/78 2 7
ref
S5001
R15981
Hyrich, 2006 Major fetal abnormalities 1st trimester retrospective cohort unexposed, sick Adjustment: No 5.00 [0.07;366.35] C 0/2   0/8 0 2
ref
Total 5 studies 2.51 [1.06;5.97] 62 380
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF De Lorenzo (Controls unexposed, sick), 2020De Lorenzo, 2020 1 21.00[0.30; 1469.95]024%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Chambers (Controls, sick), 2019Chambers, 2019 2 1.10[0.45; 2.73]3022140%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Hoxha, 2017Hoxha, 2017 2.50[0.12; 50.45]257%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Weber-Schoendorfer, 2015Weber-Schoendorfer, 2015 4.15[1.86; 9.23]3015044%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Hyrich, 2006Hyrich, 2006 5.00[0.07; 366.35]024%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Total (5 studies) I2 = 31% 2.51[1.06; 5.97]623800.550.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick; 2: Controls, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.51[1.06; 5.97]6238031%NADe Lorenzo (Controls unexposed, sick), 2020 Chambers (Controls, sick), 2019 Hoxha, 2017 Weber-Schoendorfer, 2015 Hyrich, 2006 5 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 4.15[1.86; 9.23]30150 -NAWeber-Schoendorfer, 2015 1 unexposed, sickunexposed, sick 1.39[0.60; 3.18]322300%NADe Lorenzo (Controls unexposed, sick), 2020 Chambers (Controls, sick), 2019 Hoxha, 2017 Hyrich, 2006 4 Tags Adjustment   - No  - No 4.25[2.01; 8.99]321590%NADe Lorenzo (Controls unexposed, sick), 2020 Hoxha, 2017 Weber-Schoendorfer, 2015 Hyrich, 2006 4   - Yes  - Yes 1.10[0.45; 2.71]30221 -NAChambers (Controls, sick), 2019 1 All studiesAll studies 2.51[1.06; 5.97]6238031%NADe Lorenzo (Controls unexposed, sick), 2020 Chambers (Controls, sick), 2019 Hoxha, 2017 Weber-Schoendorfer, 2015 Hyrich, 2006 50.550.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-5.26.12.6290.000De Lorenzo (Controls unexposed, sick), 2020Chambers (Controls, sick), 2019Hoxha, 2017Weber-Schoendorfer, 2015Hyrich, 2006

Asymetry test p-value = 0.6440 (by Egger's regression)

slope=0.6141 (0.6738); intercept=0.5249 (1.0254); t=0.5119; p=0.6440

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded 3121, 13724, 4061, 5069, 5066

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 3.36[1.68; 6.69]653730%NADe Lorenzo (Controls unexposed, disease free), 2020 Chambers (Controls unexposed, disease free), 2019 Weber-Schoendorfer, 2015 3 unexposed, sick controlsunexposed, sick controls 1.39[0.60; 3.18]322300%NADe Lorenzo (Controls unexposed, sick), 2020 Chambers (Controls, sick), 2019 Hoxha, 2017 Hyrich, 2006 40.510.01.0